PTT-936 Alone or in Combination in Patients With Locally Advanced or Metastatic Solid Tumors

NCT06244992 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

68

Enrollment

INDUSTRY

Sponsor class

Conditions

Locally Advanced or Metastatic Solid Tumors

Interventions

DRUG: PTT-936
DRUG: Combination of PTT-936 and anti-PD-1/L1 therapy

Sponsor

Pyrotech Therapeutics, Inc.